TLPH.NASDAQTalphera, INC

Form 4: Talphera Inc. Chief Medical Officer Increases Stake in Company

Sentiment:

SEC Form 4

📋All filings for Talphera, INC
🔒Login to Follow

Shakil Aslam, Chief Medical Officer of Talphera Inc., recently purchased additional shares of the company's common stock, increasing his holdings.

Summary

  • On June 13, 2024, Shakil Aslam, the Chief Medical Officer of Talphera Inc., acquired 695 shares of common stock at a price of $0.98 per share.
  • On June 14, 2024, Aslam purchased an additional 5,000 shares at a weighted-average price of $1.0714 per share, with prices ranging from $1.07 to $1.08.
  • Following these transactions, Aslam directly owns 37,695 shares of Talphera Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The Chief Medical Officer increasing their stake in the company is generally a good sign, but the purchase is relatively small.

Positives

  • The Chief Medical Officer's increased investment could signal confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company insider believes the company's stock is undervalued. However, it's important to consider the size of the purchase relative to the insider's overall holdings and the company's market capitalization.

Stakeholder Impact

  • Shareholders may view the insider purchase as a positive signal.

Key Dates

DateDescription
06/13/2024Shakil Aslam purchased 695 shares of common stock at $0.98 per share.
06/14/2024Shakil Aslam purchased 5,000 shares of common stock at a weighted-average price of $1.0714 per share.
02/26/2025Date of signature by Martha Adler, Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.